Radiofrequency Ablation in Breast Cancer.

E. Tzoracoleftherakis,E. Sdralis,J. Maroulis,P. Ravazoula

Radiofrequency Ablation in Breast Cancer.

2009

E. Tzoracoleftherakis
E. Sdralis
J. Maroulis
P. Ravazoula

Background: Radiofrequency ablation (RFA) of breast tumors is characterized by variable efficiency. Cell viability is principally evaluated by NADH-diaphorase and Hematoxylin-eosin (HE69(24 Suppl):Abstract nr 2106.

Keywords:

Radiofrequency ablation
Breast cancer
Cancer research
Viability assay
Immunology
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations